Cargando…

Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression

Posttransplantation cyclophosphamide (PTCy) has become a popular option for haploidentical hematopoietic stem cell transplantation (HSCT). However, personalized methods to adjust immune intensity after PTCy for each patient’s condition have not been well studied. Here, we investigated the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Makoto, Meguri, Yusuke, Ikegawa, Shuntaro, Kondo, Takumi, Sumii, Yuichi, Fukumi, Takuya, Iwamoto, Miki, Sando, Yasuhisa, Sugiura, Hiroyuki, Asada, Noboru, Ennishi, Daisuke, Tomida, Shuta, Fukuda-Kawaguchi, Emi, Ishii, Yasuyuki, Maeda, Yoshinobu, Matsuoka, Ken-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222309/ https://www.ncbi.nlm.nih.gov/pubmed/34162921 http://dx.doi.org/10.1038/s41598-021-92526-z

Ejemplares similares

Donor Treg expansion by liposomal α‐galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft‐versus‐host disease
por: Sugiura, Hiroyuki, et al.
Publicado: (2021)

Hematopoietic stem cell–derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide
por: Sumii, Yuichi, et al.
Publicado: (2023)

5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
por: Sando, Yasuhisa, et al.
Publicado: (2020)

Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
por: Sando, Yasuhisa, et al.
Publicado: (2021)

Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation
por: Meguri, Yusuke, et al.
Publicado: (2022)

Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT
por: Mammadli, Mahinbanu, et al.
Publicado: (2021)

PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation
por: Al-Homsi, A. Samer, et al.
Publicado: (2023)

Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
por: Mammadli, Mahinbanu, et al.
Publicado: (2020)

Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80
por: Cassady, Kaniel, et al.
Publicado: (2018)

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
por: Zhang, Jilu, et al.
Publicado: (2019)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
por: Song, Yuan, et al.
Publicado: (2020)

Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy
por: Nawas, Mariam T., et al.
Publicado: (2023)

Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report
por: Abe, Masaya, et al.
Publicado: (2021)

Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation
por: Toubai, Tomomi, et al.
Publicado: (2015)

GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
por: Baron, Frédéric, et al.
Publicado: (2023)

Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity
por: Song, Qingxiao, et al.
Publicado: (2022)

Accumulation of T-cell-suppressive PD-L1(high) extracellular vesicles is associated with GvHD and might impact GvL efficacy
por: Baur, Rebecca, et al.
Publicado: (2023)

Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Haplo ever after: haplo PTCy for children
por: Talano, Julie-An, et al.
Publicado: (2023)

Sacrificed Lives
Publicado: (1869)

Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial
por: Zu, Yingling, et al.
Publicado: (2023)

Tipping the GVH/GVL balance by targeting HIF1α
por: Wu, Yongxia, et al.
Publicado: (2023)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
por: Rozmus, Jacob, et al.
Publicado: (2022)

Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations
por: Daido, Yusuke, et al.
Publicado: (2023)

The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation
por: Noriega, Víctor, et al.
Publicado: (2015)

Are self-sacrificing employees liked by their supervisor?
por: Bande, Belén, et al.
Publicado: (2023)

Adult T-cell Leukemia-lymphoma with Primary Breast Involvement: A Case Report and Literature Review
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy
por: Zou, Jun, et al.
Publicado: (2022)

Digitalising medical education: sacrificing skills for knowledge?
por: Ranasinghe, Lasith
Publicado: (2019)

The Pandemic of Publications: Are We Sacrificing Quality for Quantity?
por: Martins, Russell Seth, et al.
Publicado: (2020)

The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Translation, validation and exploration of the factor structure in the French version of the Posttraumatic Cognitions Inventory (PTCI)
por: Lebel, Sarah, et al.
Publicado: (2022)

Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives
por: Ikegawa, Shuntaro, et al.
Publicado: (2021)

Sacrificed: Ontario Healthcare Workers in the Time of COVID-19
por: Brophy, James T., et al.
Publicado: (2020)

Passive radiant cooling without sacrificing the aesthetics of objects
por: Dereń, Przemysław Jacek
Publicado: (2022)

Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
por: Frisoni, Paolo, et al.
Publicado: (2023)

HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age
por: Ambinder, Alexander, et al.
Publicado: (2022)

Tentacle probes: eliminating false positives without sacrificing sensitivity
por: Satterfield, Brent C., et al.
Publicado: (2007)

Enabling Genomic-Phenomic Association Discovery without Sacrificing Anonymity
por: Heatherly, Raymond D., et al.
Publicado: (2013)

Justine Effect: Punishment of the Unduly Self-Sacrificing Cooperative Individuals
por: Kuběna, Aleš Antonín, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jajbacc88fq5f59f93pikp32vc